aztreonam has been researched along with E coli Infections in 31 studies
Aztreonam: A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.
aztreonam : A synthetic monocyclic beta-lactam antibiotic (monobactam), used primarily to treat infections caused by Gram-negative bacteria. It inhibits mucopeptide synthesis in the bacterial cell wall, thereby blocking peptidoglycan crosslinking.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The activity of gentamicin is known to be decreased in acidic environments, and both the peritoneum during peritonitis and the interior of abscesses have been shown to be acidic and hypoxic." | 7.69 | Aztreonam vs. gentamicin in experimental peritonitis and intra-abdominal abscess formation. ( Adams, RB; Pruett, TL; Sawyer, RG, 1994) |
| "The penetration of aztreonam into cerebrospinal fluid was 7 to 15% and 9 to 25%, respectively, in experimental Haemophilus influenzae type b and Escherichia coli K1 meningitis." | 7.67 | Aztreonam therapy in experimental meningitis due to Haemophilus influenzae type b and Escherichia coli K1. ( McCracken, GH; Olsen, KD; Sakata, Y, 1985) |
| "Aztreonam (SQ 26,776), a new monocyclic beta-lactam agent, was compared with ampicillin, ampicillin plus chloramphenicol, and gentamicin in rabbits with experimental meningitis induced by, respectively, ampicillin-susceptible Haemophilus influenzae, ampicillin-resistant H." | 7.66 | Evaluation of aztreonam in experimental bacterial meningitis and cerebritis. ( Brodeur, JP; Foresman, P; Gratz, JC; Rodeheaver, G; Scheld, WM, 1983) |
| "However, bacteriological recurrence, related to the persistent nature of the underlying disease, occurred in 6 of the 10 patients during the 1-month follow-up period." | 6.65 | Clinical experience with aztreonam in urinary and respiratory tract infections. ( Donohoe, JF; Hollingsworth, JA; Hone, R; Keelan, PJ, 1984) |
| "The activity of gentamicin is known to be decreased in acidic environments, and both the peritoneum during peritonitis and the interior of abscesses have been shown to be acidic and hypoxic." | 3.69 | Aztreonam vs. gentamicin in experimental peritonitis and intra-abdominal abscess formation. ( Adams, RB; Pruett, TL; Sawyer, RG, 1994) |
| " The protective effect of cefotaxime, aztreonam and gentamicin in peritonitis induced by E." | 3.67 | Effect of Bacteroides fragilis on mortality induced by Escherichia coli in an experimental infection treated with cefotaxime, aztreonam or gentamicin. ( Castilla, C; Ponte, C; Santamaría, M; Soriano, F, 1989) |
| "The penetration of aztreonam into cerebrospinal fluid was 7 to 15% and 9 to 25%, respectively, in experimental Haemophilus influenzae type b and Escherichia coli K1 meningitis." | 3.67 | Aztreonam therapy in experimental meningitis due to Haemophilus influenzae type b and Escherichia coli K1. ( McCracken, GH; Olsen, KD; Sakata, Y, 1985) |
| "Aztreonam (SQ 26,776), a new monocyclic beta-lactam agent, was compared with ampicillin, ampicillin plus chloramphenicol, and gentamicin in rabbits with experimental meningitis induced by, respectively, ampicillin-susceptible Haemophilus influenzae, ampicillin-resistant H." | 3.66 | Evaluation of aztreonam in experimental bacterial meningitis and cerebritis. ( Brodeur, JP; Foresman, P; Gratz, JC; Rodeheaver, G; Scheld, WM, 1983) |
| "However, bacteriological recurrence, related to the persistent nature of the underlying disease, occurred in 6 of the 10 patients during the 1-month follow-up period." | 2.65 | Clinical experience with aztreonam in urinary and respiratory tract infections. ( Donohoe, JF; Hollingsworth, JA; Hone, R; Keelan, PJ, 1984) |
| " Dose-response relationships between antibiotic exposure and extended-spectrum-beta-lactamase-producing or AmpC-producing isolates were not demonstrated." | 1.43 | Previous Antibiotic Exposure Increases Risk of Infection with Extended-Spectrum-β-Lactamase- and AmpC-Producing Escherichia coli and Klebsiella pneumoniae in Pediatric Patients. ( Adler, AL; Elward, A; Haaland, W; Kronman, MP; Miles-Jay, A; Newland, JG; Qin, X; Weissman, SJ; Zaoutis, T; Zerr, DM; Zhou, C, 2016) |
| " A humanized aztreonam dose of 2 g every 6 h (1-h infusion) was evaluated alone and in combination with avibactam at 375 or 600 mg every 6 h (1-h infusion), targeting the percentage of the dosing interval in which free-drug concentrations remained above the MIC (fT>MIC)." | 1.39 | Human simulated studies of aztreonam and aztreonam-avibactam to evaluate activity against challenging gram-negative organisms, including metallo-β-lactamase producers. ( Crandon, JL; Nicolau, DP, 2013) |
| "The minimum dosage of antibiotics which reduced mortality in rats intraperitoneally inoculated with an Escherichia coli isolate was determined." | 1.27 | In vivo significance of the inoculum effect of antibiotics on Escherichia coli. ( Castilla, C; Fernández-Roblas, R; Ponte, C; Santamaría, M; Soriano, F, 1988) |
| "Carumonam was intermediate between ceftazidime and aztreonam as to the activity against Pseudomonas aeruginosa." | 1.27 | Antibacterial properties of carumonam (Ro 17-2301, AMA-1080), a new sulfonated monocyclic beta-lactam antibiotic. ( Angehrn, P, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (29.03) | 18.7374 |
| 1990's | 11 (35.48) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (19.35) | 24.3611 |
| 2020's | 5 (16.13) | 2.80 |
| Authors | Studies |
|---|---|
| Bitew, A | 1 |
| Bati, S | 1 |
| Bigaud, M | 1 |
| Rudolph, B | 1 |
| Briard, E | 1 |
| Beerli, C | 1 |
| Hofmann, A | 1 |
| Hermes, E | 1 |
| Muellershausen, F | 1 |
| Schubart, A | 1 |
| Gardin, A | 1 |
| Hed, S | 1 |
| Matlov Kormas, R | 1 |
| Shashar, S | 1 |
| Malyugin, BE | 1 |
| Boyko, M | 1 |
| Knyazer, B | 1 |
| Nguyen Truong, G | 1 |
| Hoang Vinh, L | 1 |
| Huynh Thu, S | 1 |
| Nguyen Thi Hong, P | 1 |
| Nguyen Quang, B | 1 |
| White, MG | 1 |
| Szczepaniak Sloane, R | 1 |
| Witt, RG | 1 |
| Reuben, A | 1 |
| Gaudreau, PO | 1 |
| Andrews, MC | 1 |
| Feng, N | 1 |
| Johnson, S | 1 |
| Class, CA | 1 |
| Bristow, C | 1 |
| Wani, K | 1 |
| Hudgens, C | 1 |
| Nezi, L | 1 |
| Manzo, T | 1 |
| De Macedo, MP | 1 |
| Hu, J | 2 |
| Davis, R | 1 |
| Jiang, H | 1 |
| Prieto, P | 1 |
| Burton, E | 1 |
| Hwu, P | 1 |
| Tawbi, H | 1 |
| Gershenwald, J | 1 |
| Lazar, AJ | 1 |
| Tetzlaff, MT | 1 |
| Overwijk, W | 1 |
| Woodman, SE | 1 |
| Cooper, ZA | 1 |
| Marszalek, JR | 1 |
| Davies, MA | 1 |
| Heffernan, TP | 1 |
| Wargo, JA | 1 |
| Jha, V | 1 |
| Purohit, H | 1 |
| Dafale, NA | 1 |
| Moursi, AS | 1 |
| El-Fishawy, N | 1 |
| Djahel, S | 1 |
| Shouman, MA | 1 |
| Li, C | 1 |
| Yu, L | 1 |
| Jiang, Y | 1 |
| Cui, Y | 1 |
| Liu, Y | 1 |
| Shi, K | 1 |
| Hou, H | 1 |
| Liu, M | 1 |
| Zhang, W | 2 |
| Zhang, J | 1 |
| Zhang, C | 1 |
| Chen, M | 3 |
| Lu, L | 1 |
| Zheng, P | 1 |
| Wu, Z | 1 |
| Chen, X | 1 |
| Parisi, A | 1 |
| Cortellini, A | 1 |
| Venditti, O | 1 |
| Filippi, R | 1 |
| Salvatore, L | 1 |
| Tortora, G | 1 |
| Ghidini, M | 1 |
| Nigro, O | 1 |
| Gelsomino, F | 1 |
| Zurlo, IV | 1 |
| Fulgenzi, C | 1 |
| Lombardi, P | 1 |
| Roselló Keränen, S | 1 |
| Depetris, I | 1 |
| Giampieri, R | 1 |
| Morelli, C | 1 |
| Di Marino, P | 1 |
| Di Pietro, FR | 1 |
| Zanaletti, N | 1 |
| Vitale, P | 1 |
| Garajova, I | 1 |
| Spinelli, GP | 1 |
| Zoratto, F | 1 |
| Roberto, M | 1 |
| Petrillo, A | 1 |
| Aimar, G | 1 |
| Patruno, L | 1 |
| D'Orazio, C | 1 |
| Ficorella, C | 1 |
| Ferri, C | 1 |
| Porzio, G | 1 |
| Carinato, H | 1 |
| Burgy, M | 1 |
| Ferry, R | 1 |
| Fischbach, C | 1 |
| Kalish, M | 1 |
| Guihard, S | 1 |
| Brahimi, Y | 1 |
| Flesch, H | 1 |
| Bronner, G | 1 |
| Schultz, P | 1 |
| Frasie, V | 1 |
| Thiéry, A | 1 |
| Demarchi, M | 1 |
| Petit, T | 1 |
| Jung, AC | 1 |
| Wagner, P | 1 |
| Coliat, P | 1 |
| Borel, C | 1 |
| Yang, Y | 2 |
| Tang, Z | 1 |
| Ji, J | 1 |
| Yang, C | 1 |
| Han, B | 1 |
| Wang, Y | 3 |
| Guo, H | 1 |
| Gao, X | 1 |
| Wang, J | 1 |
| Cao, J | 1 |
| Zhang, B | 1 |
| Topatana, W | 1 |
| Li, S | 2 |
| Juengpanich, S | 1 |
| Lu, Z | 1 |
| Cai, X | 1 |
| Guan, W | 1 |
| Yang, S | 1 |
| Zhao, Y | 1 |
| Cheng, W | 1 |
| Song, X | 1 |
| Yao, Y | 1 |
| Xie, Y | 1 |
| Du, W | 1 |
| Li, J | 1 |
| Chen, XF | 1 |
| Fan, X | 1 |
| Hou, X | 1 |
| Liu, XY | 1 |
| Huang, JJ | 1 |
| Kang, W | 2 |
| Zhang, G | 1 |
| Zhang, H | 2 |
| Yang, WH | 1 |
| Li, YX | 1 |
| Wang, JW | 1 |
| Guo, DW | 1 |
| Sun, ZY | 1 |
| Chen, ZJ | 1 |
| Zou, LG | 1 |
| Du, XF | 1 |
| Pan, YH | 1 |
| Li, B | 1 |
| He, H | 1 |
| Xu, YC | 1 |
| Shi, D | 1 |
| Anwar, TM | 1 |
| Pan, H | 1 |
| Chai, W | 1 |
| Xu, S | 1 |
| Yue, M | 1 |
| Wang, W | 1 |
| Huang, S | 1 |
| Zou, C | 1 |
| Ding, Y | 1 |
| Wang, H | 2 |
| Pu, S | 1 |
| Liao, Y | 1 |
| Du, H | 1 |
| Wang, D | 1 |
| Chen, L | 1 |
| Niu, S | 1 |
| Harrison, MA | 1 |
| Kaur, H | 1 |
| Wren, BW | 1 |
| Dawson, LF | 1 |
| Yu, Y | 1 |
| Hu, B | 1 |
| Fan, H | 1 |
| Lian, S | 1 |
| Li, H | 1 |
| Yan, X | 1 |
| Wang, S | 1 |
| Bai, X | 1 |
| Mao, F | 1 |
| Chen, Y | 1 |
| Zhang, Q | 1 |
| Ding, X | 1 |
| Ni, B | 1 |
| Xu, X | 1 |
| Jin, X | 1 |
| Dai, Y | 1 |
| Fachler, T | 1 |
| Shteyer, E | 1 |
| Orlanski Meyer, E | 1 |
| Shemasna, I | 1 |
| Lev Tzion, R | 1 |
| Rachman, Y | 1 |
| Bergwerk, A | 1 |
| Turner, D | 1 |
| Ledder, O | 1 |
| Marianeschi, SM | 1 |
| Uricchio, N | 1 |
| Cerri, GB | 1 |
| Ghiselli, S | 1 |
| Carro, C | 1 |
| Albano, G | 1 |
| Viola, N | 1 |
| Li, Y | 2 |
| Zhang, Y | 1 |
| Liu, C | 1 |
| Li, X | 1 |
| Zhou, Q | 1 |
| Sun, C | 2 |
| Zhang, L | 2 |
| Singh, D | 1 |
| Raghunathan, V | 1 |
| Dhaliwal, M | 1 |
| Rastogi, N | 1 |
| Chadha, R | 1 |
| Yadav, SP | 1 |
| Shah, M | 1 |
| Han, JH | 1 |
| Park, H | 1 |
| Kim, HW | 1 |
| Park, KB | 1 |
| Zhou, J | 1 |
| Huang, H | 1 |
| Zhu, Q | 1 |
| Wen, F | 1 |
| Dong, Y | 1 |
| Hu, Y | 1 |
| Pan, P | 1 |
| Hong, C | 1 |
| Fang, L | 1 |
| Poirel, L | 1 |
| Ortiz de la Rosa, JM | 1 |
| Sadek, M | 1 |
| Nordmann, P | 1 |
| Jalil, MB | 1 |
| Al Atbee, MYN | 1 |
| Gu, S | 1 |
| Lai, J | 1 |
| Zhu, X | 1 |
| Ji, T | 1 |
| Feng, J | 1 |
| Zhao, L | 1 |
| Li, Z | 2 |
| Dong, L | 1 |
| Hou, G | 1 |
| Zhu, Y | 1 |
| He, C | 1 |
| Geng, H | 1 |
| Pang, D | 1 |
| Afsharikhah, S | 1 |
| Ghanbarpour, R | 1 |
| Mohseni, P | 1 |
| Adib, N | 1 |
| Bagheri, M | 1 |
| Jajarmi, M | 1 |
| Namaei, MH | 1 |
| Yousefi, M | 1 |
| Ziaee, M | 1 |
| Salehabadi, A | 1 |
| Ghannadkafi, M | 1 |
| Amini, E | 1 |
| Askari, P | 1 |
| Crandon, JL | 1 |
| Nicolau, DP | 1 |
| Tian, GB | 1 |
| Huang, YM | 1 |
| Fang, ZL | 1 |
| Qing, Y | 1 |
| Zhang, XF | 1 |
| Huang, X | 1 |
| McWilliams, CS | 1 |
| Condon, S | 1 |
| Schwartz, RM | 1 |
| Ginocchio, CC | 1 |
| Alm, RA | 1 |
| Johnstone, MR | 1 |
| Lahiri, SD | 1 |
| Zerr, DM | 1 |
| Miles-Jay, A | 1 |
| Kronman, MP | 1 |
| Zhou, C | 1 |
| Adler, AL | 1 |
| Haaland, W | 1 |
| Weissman, SJ | 1 |
| Elward, A | 1 |
| Newland, JG | 1 |
| Zaoutis, T | 1 |
| Qin, X | 1 |
| Scheld, WM | 1 |
| Brodeur, JP | 1 |
| Gratz, JC | 1 |
| Foresman, P | 1 |
| Rodeheaver, G | 1 |
| Hollingsworth, JA | 1 |
| Donohoe, JF | 1 |
| Hone, R | 1 |
| Keelan, PJ | 1 |
| Sawyer, RG | 1 |
| Adams, RB | 1 |
| Pruett, TL | 1 |
| Lun, MT | 3 |
| Amatucci, AM | 2 |
| Raponi, G | 4 |
| Filadoro, F | 2 |
| Bartolazzi, A | 1 |
| Fraioli, R | 2 |
| Natali, PG | 2 |
| Mancini, C | 3 |
| Lorino, G | 1 |
| Nazzari, C | 1 |
| Gaeta, A | 1 |
| Ilahi, OA | 1 |
| Swarna, U | 1 |
| Hamill, RJ | 1 |
| Young, EJ | 1 |
| Tullos, HS | 1 |
| Soriano, F | 3 |
| García-Corbeira, P | 1 |
| Ponte, C | 3 |
| Fernández-Roblas, R | 2 |
| Gadea, I | 1 |
| Cantón, R | 1 |
| Morosini, MI | 1 |
| Ballestero, S | 1 |
| Alvarez, ME | 1 |
| Escobar, H | 1 |
| Máiz, L | 1 |
| Baquero, F | 1 |
| Moland, ES | 1 |
| Sanders, CC | 1 |
| Thomson, KS | 1 |
| Fayed, DF | 1 |
| Dahmash, NS | 1 |
| Saddique, AA | 1 |
| Shibl, AM | 1 |
| Keller, N | 1 |
| Overbeek, BP | 1 |
| Rozenberg-Arska, M | 1 |
| Torensma, R | 1 |
| Verhoef, J | 1 |
| van Ogtrop, ML | 1 |
| Mattie, H | 1 |
| Guiot, HF | 1 |
| van Strijen, E | 1 |
| Sekh, BR | 1 |
| van Furth, R | 1 |
| Santamaría, M | 2 |
| Castilla, C | 2 |
| Kafetzis, D | 1 |
| Papadimitriou, G | 1 |
| Stavridis, C | 1 |
| Sinaniotis, C | 1 |
| Papoulias, G | 1 |
| Isani, Z | 1 |
| Rehman, N | 1 |
| Adil, N | 1 |
| el Messidi, M | 1 |
| Childs, SJ | 1 |
| McCracken, GH | 1 |
| Sakata, Y | 1 |
| Olsen, KD | 1 |
| Angehrn, P | 1 |
1 review available for aztreonam and E coli Infections
| Article | Year |
|---|---|
Concomitant crystal and septic arthritis.
Topics: Adult; Aged; Aged, 80 and over; Arthritis, Gouty; Arthritis, Infectious; Aztreonam; Escherichia coli | 1996 |
3 trials available for aztreonam and E coli Infections
| Article | Year |
|---|---|
Clinical experience with aztreonam in urinary and respiratory tract infections.
Topics: Adult; Aged; Anti-Bacterial Agents; Aztreonam; Clinical Trials as Topic; Escherichia coli Infections | 1984 |
Evaluation of aztreonam in the treatment of serious gram-negative infections in a university hospital in Saudi Arabia.
Topics: Acinetobacter; Acinetobacter Infections; Adult; Aztreonam; Bacteremia; Citrobacter; Cross Infection; | 1992 |
Aztreonam in the treatment of urinary tract infection.
Topics: Anti-Bacterial Agents; Aztreonam; Cefamandole; Cross Infection; Drug Resistance, Microbial; Escheric | 1985 |
27 other studies available for aztreonam and E coli Infections
| Article | Year |
|---|---|
Topics: Animals; Anti-Bacterial Agents; Antibodies, Protozoan; Antifungal Agents; Auranofin; Azabicyclo Comp | 2021 |
Impact of Acquired Broad-Spectrum β-Lactamases on Susceptibility to Cefiderocol and Newly Developed β-Lactam/β-Lactamase Inhibitor Combinations in Escherichia coli and Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; beta-Lactamase Inhibitors; beta-Lactamases; | 2022 |
The prevalence of multiple drug resistance Escherichia coli and Klebsiella pneumoniae isolated from patients with urinary tract infections.
Topics: Ampicillin; Anti-Bacterial Agents; Aztreonam; Cefepime; Ceftazidime; Ceftriaxone; Ciprofloxacin; Dru | 2022 |
Drug resistance characteristics and molecular typing of Escherichia coli isolates from neonates in class A tertiary hospitals: A multicentre study across China.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamases; Carbapenems; Cefotaxime; Child; Ciprofloxacin; Do | 2022 |
High prevalence of β-lactam and fluoroquinolone resistance in various phylotypes of Escherichia coli isolates from urinary tract infections in Jiroft city, Iran.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactam Resistance; beta-Lactamases; Cefotaxime; Ceftazidime; | 2023 |
First Report of Prevalence of CTX-M-15-Producing Escherichia coli O25b/ST131 from Iran.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamases; Cefotaxime; Ciprofloxacin; Clone Cells; Drug Resi | 2017 |
Human simulated studies of aztreonam and aztreonam-avibactam to evaluate activity against challenging gram-negative organisms, including metallo-β-lactamase producers.
Topics: Animals; Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; Bacterial Proteins; beta-Lactamases | 2013 |
CTX-M-137, a hybrid of CTX-M-14-like and CTX-M-15-like β-lactamases identified in an Escherichia coli clinical isolate.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactam Resistance; beta-Lactamases; Cefotaxime; Ceftazidime; | 2014 |
Incidence of extended-spectrum-β-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates that test susceptible to cephalosporins and aztreonam by the revised CLSI breakpoints.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamases; Cephalosporins; Escherichia coli; Escherichia col | 2014 |
Characterization of Escherichia coli NDM isolates with decreased susceptibility to aztreonam/avibactam: role of a novel insertion in PBP3.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; beta-Lactam Resistance; beta-Lactamases; Com | 2015 |
Previous Antibiotic Exposure Increases Risk of Infection with Extended-Spectrum-β-Lactamase- and AmpC-Producing Escherichia coli and Klebsiella pneumoniae in Pediatric Patients.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Aztreonam; Bacterial Proteins; beta-Lactamases; Cefepime; | 2016 |
Evaluation of aztreonam in experimental bacterial meningitis and cerebritis.
Topics: Animals; Anti-Bacterial Agents; Aztreonam; Encephalitis; Escherichia coli Infections; Female; Gentam | 1983 |
Aztreonam vs. gentamicin in experimental peritonitis and intra-abdominal abscess formation.
Topics: Abdominal Abscess; Animals; Aztreonam; Bacteroides fragilis; Bacteroides Infections; beta-Lactam Res | 1994 |
Murine monoclonal antibody elicited with antibiotic-exposed Escherichia coli exerts protective capacity in experimental bacterial infections.
Topics: Animals; Antibodies, Monoclonal; Aztreonam; Blood Bactericidal Activity; Cross Reactions; Enzyme-Lin | 1994 |
Reactivity and protective capacity of a polyclonal antiserum derived from mice immunized with antibiotic exposed Escherichia coli.
Topics: Animals; Aztreonam; Escherichia coli; Escherichia coli Infections; Immune Sera; Immunization, Passiv | 1993 |
Characterisation and protective capacity of monoclonal antibodies elicited in mice against protein epitopes of antibiotic-exposed Escherichia coli.
Topics: Animals; Antibodies, Bacterial; Antibodies, Monoclonal; Antibody Specificity; Antigens, Bacterial; A | 1997 |
Correlation of pharmacodynamic parameters of five beta-lactam antibiotics with therapeutic efficacies in an animal model.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Aztreonam; Cefazolin; Cefotaxime; Disease Models, Animal | 1996 |
Lung colonization with Enterobacteriaceae producing extended-spectrum beta-lactamases in cystic fibrosis patients.
Topics: Adolescent; Aztreonam; beta-Lactamases; Ceftazidime; Cystic Fibrosis; Drug Resistance, Microbial; Es | 1997 |
Can results obtained with commercially available MicroScan microdilution panels serve as an indicator of beta-lactamase production among escherichia coli and Klebsiella isolates with hidden resistance to expanded-spectrum cephalosporins and aztreonam?
Topics: Aztreonam; beta-Lactam Resistance; beta-Lactamases; Cephalosporin Resistance; Cephalosporins; Escher | 1998 |
Immunization of mice with antibiotic-treated Escherichia coli results in enhanced protection against challenge with homologous and heterologous bacteria.
Topics: Animals; Anti-Bacterial Agents; Aztreonam; Blood Bactericidal Activity; Ceftriaxone; Ciprofloxacin; | 1991 |
Comparison of the effects of aztreonam and tigemonam against Escherichia coli and Klebsiella pneumoniae in vitro and in vivo.
Topics: Animals; Aztreonam; Cells, Cultured; Chromatography, High Pressure Liquid; Dose-Response Relationshi | 1991 |
Effect of Bacteroides fragilis on mortality induced by Escherichia coli in an experimental infection treated with cefotaxime, aztreonam or gentamicin.
Topics: Animals; Aztreonam; Bacteroides fragilis; Bacteroides Infections; Cefotaxime; Escherichia coli Infec | 1989 |
In vivo significance of the inoculum effect of antibiotics on Escherichia coli.
Topics: Animals; Anti-Bacterial Agents; Aztreonam; Cefmetazole; Cefotaxime; Cefoxitin; Cephamycins; Drug Res | 1988 |
Treatment of pyelonephritis with aztreonam: kinetic study in children.
Topics: Aztreonam; Child; Child, Preschool; Escherichia coli Infections; Humans; Infant; Pseudomonas Infecti | 1987 |
Aztreonam in the treatment of gram-negative meningitis in children.
Topics: Anti-Bacterial Agents; Aztreonam; Child, Preschool; Escherichia coli Infections; Gram-Negative Bacte | 1987 |
Aztreonam therapy in experimental meningitis due to Haemophilus influenzae type b and Escherichia coli K1.
Topics: Animals; Anti-Bacterial Agents; Aztreonam; Escherichia coli Infections; Male; Meningitis; Meningitis | 1985 |
Antibacterial properties of carumonam (Ro 17-2301, AMA-1080), a new sulfonated monocyclic beta-lactam antibiotic.
Topics: Animals; Anti-Bacterial Agents; Aztreonam; Bacteria; Enterobacteriaceae; Escherichia coli Infections | 1985 |